KR
Kishu Ranjan
Yale University, Maharaja Sayajirao University of Baroda, Sardar Patel University
0000-0003-1256-181X
About
Tumor immunologist investigating how metabolic and microenvironmental pressures shape immune dysfunction, metastatic progression, and immunotherapy resistance in solid tumors. My research program integrates human tumor cohorts, spatial profiling, functional epigenomics, and patient-derived 3D models to identify immune-evasive cellular states, define predictive biomarkers, and develop mechanism-guided therapeutic strategies.
Employment
-
Yale University Associate Research Scientist2016 - Present
Education
-
Yale University Postdoctoral Associate2021 - 2022
-
Yale University Postdoctoral Associate2016 - 2021
-
Maharaja Sayajirao University of Baroda PhD2012 - 2016
-
Maharaja Sayajirao University of Baroda MS2007 - 2009
-
Sardar Patel University BS in Biotechnology2004 - 2007
Projects & Funding
Projects & funding information is unavailable.
Publications (24)
- The tumor microenvironment of non-small cell lung cancer impairs immune cell function in people with HIV. Save
- IL-4 mediated TAP2 downregulation is a dominant and reversible mechanism of immune evasion and immunotherapy resistance in non-small cell lung cancer. Save
- Molecular Perspective of Proteases in Modeling of Cell Death Signaling Save
- Molecular Perspective on Proteases: Regulation of Programmed Cell Death Signaling, Inflammation and Pathological Outcomes Save
- Editorial: Engineered medicines to mitigate resistance to cancer immunotherapy. Save
- Cellular Dynamics of Fas-Associated Death Domain in the Regulation of Cancer and Inflammation Save
- Cellular Dynamics of Fadd in the Regulation of Cancer and Inflammatory Diseases Save
- Insights of Endocytosis Signaling in Health and Disease Save
- Insights of Endocytosis Signaling in Health and Disease Save
- Ubiquitination of ATF6 by disease-associated RNF186 promotes the innate receptor-induced unfolded protein response Save